CODA- a device to allow the safe transfer of fluids from the DUET, a retractable safety syringe

当患者体内的注射器意外刺穿另一个人的皮肤时，就会发生针头损伤，造成血源性病毒（例如乙型肝炎和丙型肝炎以及艾滋病毒）的风险。在美国，nsi给NHS带来的成本分别为5亿英镑和20亿美元。“安全注射器”市场已经迅速增长到30亿美元，但nsi并没有显著下降，美国的数据显示，大多数nsi是在使用安全注射器时发生的。C-Major Limited已经证明了DUET的概念，DUET是一种新型的安全注射器，由一系列专利保护，克服了现有注射器的局限性，具有专利的可伸缩针头，单手按钮激活，适用于吸入和注射。试验表明安全性得到了显著提高，但也强调了用于吸入时仍有nsi的风险。因此，该项目的目的是证明CODA的可行性，CODA是一种小型塑料适配器，通过重新打开流体路径，可以在针头收回后安全地分配任何吸入的液体。带有DUET的CODA将通过区域特定经销商销售。最初的目标市场将是急症室、护理人员和诊所，并将扩展到更广泛的医疗应用程序和糖尿病患者。团队：Aubrey Dunford，项目经理；商务经理西蒙·道格拉斯；Philip Brown，技术总监；史蒂夫·多布森，运营经理。

A needle-stick injury (NSI) occurs when a syringe that has been in a patient, accidentally punctures another person’s skin posing risk of bloodborne viruses (e.g. Hepatitis B and C and HIV). Cost of NSIs to the NHS is £500m and $2bn in the US. The “safe syringe” market has grown quickly to >$3bn but NSIs are not falling significantly and USA data shows most occur whilst using safe syringes. C-Major Limited has proven the concept of DUET, a novel safety syringe protected by a portfolio of patents which overcomes the limitations of existing syringes with patented retractable needle, one handed push button activation and application in both aspiration & injection. Trials have shown safety is significantly improved, but have highlighted there is still a risk of NSIs when used for aspiration. The objective of this project to therefore prove feasibility of CODA, a small plastic adaptor which enables safe dispensing of any aspirated fluid after retraction of the needle by reopening the fluid path. CODA with DUET will be sold via territory specific distributors. Initial target markets will be A&E units, paramedics and walk in clinics, with expansion into wider medical apps & diabetics. Team: Aubrey Dunford, Project Manager; Simon Douglas, Commercial Manager; Philip Brown, Tech Director; Steve Dobson, Ops Manager.